TRACON Pharmaceuticals, Inc. (TCON)
NASDAQ: TCON · IEX Real-Time Price · USD
1.763
-0.027 (-1.51%)
Apr 26, 2024, 12:35 PM EDT - Market open
TRACON Pharmaceuticals Stock Forecast
TCON's stock price has decreased by -88.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for TCON stock have an average target of 60, which predicts an increase of 3,303.29% from the current stock price of 1.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TCON stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $60 | Strong Buy | Maintains | $120 → $60 | +3,303.29% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $140 → $120 | Strong Buy | Maintains | $140 → $120 | +6,706.58% | Mar 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +7,841.01% | Nov 20, 2023 |
| JonesTrading | JonesTrading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 21, 2023 |
| Baird | Baird | Buy Maintains $140 → $60 | Buy | Maintains | $140 → $60 | +3,303.29% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 12.05M
Revenue Next Year
1.79M
EPS This Year
-0.23
from -2.20
EPS Next Year
-0.17
from -0.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 3.7M | 46.3M | 92.4M | 159.4M |
| Avg | n/a | 1.8M | 27.9M | 85.7M | 144.8M |
| Low | n/a | n/a | 13.0M | 78.5M | 129.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 2,494.1% | 231.4% | 86.0% |
| Avg | - | - | 1,462.0% | 207.4% | 68.9% |
| Low | - | - | 630.2% | 181.4% | 50.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.21 | -0.06 | 0.11 |
| Avg | -0.23 | -0.17 | 0.05 |
| Low | -0.25 | -0.26 | - |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.